BART
Bladder Cancer Adjuvant Radiotherapy Trial
- NCT02951325 ↗
- Active, not recruiting
- Tata Memorial Centre
- Deep
We haven't built an HCP commentary report on BART (postcystectomy muscle-invasive bladder cancer; tests no drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Questions raised in the commentary
Automated from the 40 newest of 58 indexed sources (Sep 2024 – Oct 2026). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice.
- Whether adjuvant radiotherapy should be used for high-risk disease in current practice
- Whether adjuvant radiotherapy improves overall survival
- How adjuvant radiotherapy can be integrated with contemporary systemic therapy, including immunotherapy
Also discussed: toxicity.
Indexed commentary on BART so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 46 | |
| Podcasts | 6 | |
| X videos | 4 | |
| YouTube | 2 |
The trial
ClinicalTrials.gov- Official title
- Prospective Randomized Trial of Adjuvant Radiotherapy Following Surgery and Chemotherapy in Muscle Invasive Transitional Cell Carcinoma of Urinary Bladder
- Phase
- Phase 3
- Status
- Active, not recruiting
- Conditions
- Bladder Cancer; Urothelial Carcinoma Bladder
- Interventions
- Adjuvant RT
- Arms
- Standard · No intervention
- Test · Experimental
- Enrollment
- 153 (estimated)
- Primary outcomes
- Improvement in loco-regional relapse free survival (LRFS)
- Sponsor
- Tata Memorial Centre
- Start
- Jun 2, 2016
- Primary completion
- May 8, 2024
- Results posted
- No
- Registry record
- NCT02951325 · updated Feb 13, 2025
Publications
linked from the registry- Murthy V, Maitre P, Singh M, Pal M, Arora A, Pujari L, Kapoor A, Pandey H, Sharma R, Gudipudi D, Joshi A, Prabhash K, Noronha V, Menon S, Mehta P, Bakshi G, Prakash G. Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer. Clin Oncol (R Coll Radiol). 2023 Sep;35(9):e506-e515. doi: 10.1016/j.clon.2023.04.010. Epub 2023 May 5. PubMed 37208232
- Murthy V, Maitre P, Bakshi G, Pal M, Singh M, Sharma R, Gudipudi D, Pujari L, Pandey H, Bandekar B, Joseph D, Krishnatry R, Phurailatpam R, Kannan S, Arora A, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Prakash G. Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2025 Mar 1;121(3):728-736. doi: 10.1016/j.ijrobp.2024.09.040. Epub 2024 Sep 29. PubMed 39353477
- Murthy V, Maitre P, Pal M, Arora A, Phurailatpam R, Sharma R, Gudipudi D, Rajappa S, Pujari L, Bandekar B, Joseph D, Kannan S, Krishnatry R, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Bakshi G, Prakash G. Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer. J Clin Oncol. 2026 Jul;44(19):1812-1821. doi: 10.1200/JCO-25-02093. Epub 2026 May 21. PubMed 42166701